Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 2
2012 3
2013 3
2014 3
2015 4
2016 4
2018 1
2019 4
2020 10
2021 5
2022 8
2023 6
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

43 results

Results by year

Filters applied: . Clear all
Page 1
Reply.
Arase Y, Kagawa T. Arase Y, et al. Hepatology. 2020 Mar;71(3):1132-1133. doi: 10.1002/hep.30999. Epub 2020 Mar 4. Hepatology. 2020. PMID: 31628871 Free PMC article. No abstract available.
Reply.
Arase Y, Kagawa T, Tanaka A. Arase Y, et al. Hepatology. 2020 Jul;72(1):360-361. doi: 10.1002/hep.31084. Hepatology. 2020. PMID: 31863598 Free PMC article. No abstract available.
Association Between Immune-Related Adverse Events and Survival in Patients with Hepatocellular Carcinoma Treated With Atezolizumab Plus Bevacizumab.
Fukushima T, Morimoto M, Kobayashi S, Ueno M, Uojima H, Hidaka H, Kusano C, Chuma M, Numata K, Tsuruya K, Arase Y, Kagawa T, Hattori N, Ikeda H, Watanabe T, Tanaka K, Maeda S. Fukushima T, et al. Among authors: arase y. Oncologist. 2023 Jul 5;28(7):e526-e533. doi: 10.1093/oncolo/oyad090. Oncologist. 2023. PMID: 37023703 Free PMC article.
Impact of body composition for patients with hepatocellular carcinoma who received atezolizumab plus bevacizumab therapy.
Uojima H, Chuma M, Hidaka H, Tsuda T, Kobayashi S, Hattori N, Ogushi K, Arase Y, Take A, Sakaguchi Y, Tomoko A, Nishigori S, Wanatanbe T, Numata K, Morimoto M, Kagawa T, Kako M, Kusano C. Uojima H, et al. Among authors: arase y. Eur J Gastroenterol Hepatol. 2023 Aug 1;35(8):865-873. doi: 10.1097/MEG.0000000000002581. Epub 2023 Jun 6. Eur J Gastroenterol Hepatol. 2023. PMID: 37395239
Usefulness of autotaxin for the complications of liver cirrhosis.
Shao X, Uojima H, Setsu T, Okubo T, Atsukawa M, Furuichi Y, Arase Y, Hidaka H, Tanaka Y, Nakazawa T, Kako M, Kagawa T, Iwakiri K, Terai S, Koizumi W. Shao X, et al. Among authors: arase y. World J Gastroenterol. 2020 Jan 7;26(1):97-108. doi: 10.3748/wjg.v26.i1.97. World J Gastroenterol. 2020. PMID: 31933517 Free PMC article.
A case of breast cancer with extensive colon metastasis.
Imai J, Hanamura T, Kawanishi A, Ueda T, Mishima Y, Ito A, Shirataki Y, Morimachi M, Kodama T, Sato H, Kaneko M, Sano M, Teramura E, Monma M, Tsuda S, Tsuruya K, Mizukami H, Arase Y, Fujisawa M, Miyahara S, Nakamura N, Suzuki T, Matsushima M, Suzuki H, Takashimizu S, Kagawa T, Nishizaki Y. Imai J, et al. Among authors: arase y. DEN Open. 2022 Nov 27;3(1):e189. doi: 10.1002/deo2.189. eCollection 2023 Apr. DEN Open. 2022. PMID: 36447634 Free PMC article.
The Risk of Cirrhosis and Its Complications Based on PNPLA3 rs738409 G Allele Frequency.
Shao X, Uojima H, Arai T, Ogawa Y, Setsu T, Atsukawa M, Furuichi Y, Arase Y, Horio K, Hidaka H, Nakazawa T, Kako M, Kagawa T, Iwakiri K, Nakajima A, Terai S, Tanaka Y, Koizumi W. Shao X, et al. Among authors: arase y. Dig Dis. 2022;40(5):625-634. doi: 10.1159/000521062. Epub 2021 Nov 22. Dig Dis. 2022. PMID: 34808618 Free PMC article.
43 results